hotspot -WSS

hotspot

author：hotspot 2025-10-01 21:40:04 - browse：5

An experimental drug from Insmed Incorporated successfully reduced lung problems among patients with an airway disease in a closely watched Phase 3 trial, sending the company’s share price soaring early Tuesday.

The drug, brensocatib, reduced so-called pulmonary exacerbations by roughly 20% versus placebo in patients with bronchiectasis, hitting the trial’s primary endpoint. The trial, called the ASPEN study, tested two dosages of the drug, and the company said both significantly cut rates of pulmonary exacerbations.

Insmed shares more than doubled in pre-market trading. Analysts have forecasted that brensocatib could lead to billions of dollars in annual sales if approved.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Brain MRIs reveal impact of 'toxic stress' on Black children

leisure time

knowledge

WSS

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Why the advice to take all your antibiotics may be wrong

Novel spinal cord stimulator treats paralysis without surgery

Prosecutors say FTX founder Sam Bankman

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why Marc Tessier

In Memoriam: Notable people who died in 2023

GSK’s asthma push continues as drug succeeds in Phase 3 trials

How to save PrEP access — and even expand it

It's time to take a new tack for treating Alzheimer's

The high cost of giving birth even with insurance

Brain technologies pose threats that are all too real, experts warn

Anesthesiologist group: stop taking Ozempic before surgery

Can gargling with Listerine treat gonorrhea of the mouth?

knowledge

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Empower primary care with adequate payments and technology

Pfizer's RSV vaccine recommended for approval in Europe

Lawmakers grill UnitedHealth CEO on Change cyberattack

Hey, doctors: Don't be no

Welsh Carson private equity firm escapes from FTC antitrust case

Wikipedia

leisure time

knowledge

hotspot